NO20055582L - Preparater og fremgangsmater omfattende gastrinforbindelser - Google Patents

Preparater og fremgangsmater omfattende gastrinforbindelser

Info

Publication number
NO20055582L
NO20055582L NO20055582A NO20055582A NO20055582L NO 20055582 L NO20055582 L NO 20055582L NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 L NO20055582 L NO 20055582L
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
beneficial effects
gastrin
Prior art date
Application number
NO20055582A
Other languages
English (en)
Other versions
NO20055582D0 (no
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/no
Publication of NO20055582L publication Critical patent/NO20055582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Oppfinnelsen vedrører generelt nye sammensetninger og fremgangsmåter omfattende en gastrinforbindelse. Sammensetningene og fremgangsmåtene tilveiebringer fordelaktige effekter, særlig vedvarende fordelaktige effekter, i behandlingen av diabetes.
NO20055582A 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser NO20055582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 NO20055582D0 (no) 2005-11-25
NO20055582L true NO20055582L (no) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (no) 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser

Country Status (11)

Country Link
EP (1) EP1648495A2 (no)
JP (1) JP2007513059A (no)
CN (1) CN1829528A (no)
AU (1) AU2004243541A1 (no)
BR (1) BRPI0410710A (no)
CA (1) CA2527186A1 (no)
MX (1) MXPA05012605A (no)
NO (1) NO20055582L (no)
PL (1) PL379145A1 (no)
RU (1) RU2005140518A (no)
WO (1) WO2004105780A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040064605A (ko) 2001-01-12 2004-07-19 와라타 파마수티컬즈, 인크. 가스트린/ｃｃｋ 수용체 리간드 및 ｅｇｆ 수용체리간드를 함유하는, 섬 신생 유발을 위한 조성물
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
ATE445407T1 (de) 2002-06-07 2009-10-15 Waratah Pharmaceuticals Inc Methoden und kompositionen um diabetes zu behandeln
AU2005207870B2 (en) * 2004-01-30 2010-08-19 Waratah Pharmaceuticals, Inc. The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
JPH09511384A (ja) * 1994-01-24 1997-11-18 リサーチ トライアングル ファーマシューティカルズ リミテッド 若年型糖尿病の治療
KR20040064605A (ko) * 2001-01-12 2004-07-19 와라타 파마수티컬즈, 인크. 가스트린/ｃｃｋ 수용체 리간드 및 ｅｇｆ 수용체리간드를 함유하는, 섬 신생 유발을 위한 조성물
CA2501677A1 (en) * 2002-10-22 2004-05-06 Waratah Pharmaceuticals, Inc. Treatment of diabetes

Also Published As

Publication number Publication date
AU2004243541A1 (en) 2004-12-09
EP1648495A2 (en) 2006-04-26
WO2004105780A3 (en) 2005-01-20
BRPI0410710A (pt) 2006-06-13
PL379145A1 (pl) 2006-07-24
NO20055582D0 (no) 2005-11-25
CN1829528A (zh) 2006-09-06
RU2005140518A (ru) 2007-07-10
CA2527186A1 (en) 2004-12-09
JP2007513059A (ja) 2007-05-24
WO2004105780A2 (en) 2004-12-09
MXPA05012605A (es) 2006-02-22

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
MX2007005933A (es) Compuestos de acetamida como fungicidas.
HK1079519A1 (en) Furyl compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
MX2007005408A (es) Compuestos de aminoquinazolinas.
IN2012DN02609A (no)
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
NO20055741L (no) Nye kjemiske forbindelser
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
ATE477256T1 (de) Thienylverbindungen
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
MXPA05011962A (es) Oxiarenos substituidos.
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
MXPA06000372A (es) Compuestos de silicio y su uso.
NO20053562L (no) Nye aminobenzofenonforbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application